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Available online 9 November 2016Peripheral bloodmononuclear cells (PBMCs) were collected from 55-year old male patient with a conﬁrmed di-
agnosis of hemorrhagic Moyamoya disease (MMD). PBMCs were reprogrammed using Sendai virus particles de-
livering the four Yamanaka factors. A footprint-free hiPSC line was characterized by the expression of
pluripotency markers and a normal karyotype. These cells were able to give rise to Embryoid Bodies and to a
progeny of differentiated cells belonging to the 3 germ layers. This hiPSC line represents a suitable tool formodel-
ling in vitroMMD disease to investigate the cellular mechanisms underlying the occurrence of this pathology.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource Table:ame of Stem Cell
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ey transcription
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Reprogramming Kit - Thermo Fisher Scientiﬁc)uthentication Cell line was characterized for its homogeneity and
identity by these assays: RT-PCR, WB and2708@cumc.columbia.edu
no.Conti@unitn.it (L. Conti).
iology, LIFE and BRAIN Center,
opment, Columbia University,
pen access article under the CC BY-NC-ND license (http://creatiimmunoﬂuorescence to test the expression of
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Papa Giovanni XXIII Hospital Ethical Board.Resource details
Blood sample was donated by a 55-year old male patient affected by
Moyamoya disease (MMD; Papa Giovanni XXIII Hospital, Bergamo,
Italy). Patient was admitted to the emergency room for a large intrace-
rebral hematoma of the left frontal lobe. The computed tomography an-
giography did not show any vascular malformation but, on the other
side, disclosed a signiﬁcant stenosis of the distal intracranial internal ca-
rotid artery on both sides suggestive of MMD. Postoperative digital sub-
traction angiography conﬁrmed the diagnosis of MMD.
Patient's PBMCs were puriﬁed and infected with Sendai virus parti-
cles (Yang et al. 2008), delivering 3 different vectors encoding for the
Yamanaka reprogramming genes (OCT4, SOX2, KLF4, and c-Myc;
Takahashi et al., 2007). After two weeks, several colonies with the typi-
cal iPSC-like phenotype appeared in the cultures. These were thenvecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of MMD HEM#30 iPSC line. A: Typical phenotype of a MMD HEM#30 iPSC colony and karyogram showing normal 46 chromosomes (XY). Immunophenotypical
analysis revealing the homogeneous expression of the pluripotencymarkers OCT4, Nanog, TRA-1-60, SOX2 (40×) performed on passage 10 cultures. B: RT-PCR displaying the expression
of the pluripotency-associated genes at passages 0 and 10 MMD HEM#30 iPSCs cultures and another MMD HEM hiPSC clone (#6). Loss of Sendai virus genome is shown in passage 10
cultures. Commercial hiPSCs were used as positive control for pluripotency-associated genes. C: Western blot analysis showing protein expression levels of pluripotency markers in
MMD HEM#30 iPSCs and in several clones isolated from reprogrammed PBMCs by the same patient. Commercial hiPSCs were used as positive control.
624 M. Cardano et al. / Stem Cell Research 17 (2016) 623–626picked about 20 days post-transduction. Different clones were isolated,
expanded and their phenotype was monitored along the time. MMD
HEM#30 iPSC line and other cloneswere further characterized by differ-
ent assays. MMD HEM#30 iPSC was shown to be regularly expandable
at purity, exhibited a normal diploid 46, XY karyotype, without detect-
able abnormalities, and the expression of OCT4, Nanog, SOX2 and
TRA-1-60 pluripotency markers (Fig. 1A) (Itskovitz-Eldor et al., 2000;
Carpenter et al., 2003). The lack of residual Sendai virus particles was
conﬁrmed at passage 10 (Fusaki et al., 2009), suggesting that the ex-
pression of OCT4, SOX2, KLF4, and c-Myc was indicative of an effective
complete reprogramming process (Fig. 1B). The in vitro differentiation
competence was assessed by Embryoid Body assay, giving rise to ma-
ture cells belonging to the three different germ layers, immunoreactive
for ectoderm (βIII-Tubulin), mesoderm (α-SMA) and endoderm
(TROMA-1) markers (Fig. 2A) (Itskovitz-Eldor et al., 2000; Carpenter
et al., 2003). Moreover, differentiated MMD HEM#30 iPSCs expressed
transcript levels of FGF5 (ectoderm), Nestin (neuro-ectoderm), T-
Brachyury (mesoderm), SOX-17 (endoderm) comparable to those
assessed in a differentiated reference commercial hiPSC line (Fig. 2B).Materials and methods
PBMCs collection and freezing
Patient's PBMCs were isolated in BD Vacutainer CPT Cell Preparation
tubes and separated by centrifugation (30 min, 1800g at room temper-
ature). Then they were resuspended in 35 ml of PBS, centrifuged at
300 g for 15 min at room temperature and aliquots of 2 ∗ 106 cellsFig. 2. In vitro differentiation competence of MMD HEM#30 iPSC line. A: Day 4 Embryoid bo
immunopositive for ectodermal (β3-Tubulin), mesodermal (α-SMA) and endodermal (TRO
Brachyury (mesoderm) and SOX-17 (endoderm) expression levels assessed by qRT-PCR were
iPSCs and commercial hiPSCs used as reference.were cryopreserved in fetal bovine serum (FBS) supplemented with
10% DMSO.
PBMCs thawing and infection with Sendai virus
Thawed cells were cultured in 24 well-plates in PBMC expansion
medium, composed by StemPro-34 Serum Free Medium Basal Medium
(Thermo Fisher Scientiﬁc), StemPro-34 Nutrient Supplement, 200 mM
GlutaMAX (Thermo Fisher Scientiﬁc), 1% penicillin/streptomycin (Life
Technologies), 100 ng/ml stem cell factor (SCF, Prepotech), 100 ng/ml
FLT-3 (Thermo Fisher Scientiﬁc), 20 ng/ml Interleukin-6 (IL-6) (Thermo
Fisher Scientiﬁc), 20 ng/ml Interleukin-3 (IL-3) (Thermo Fisher Scientif-
ic). The medium was replaced daily.
After 4 days, PBMCs were transduced in feeder-free conditions with
the components provided with the CytoTune-iPS 2.0 Sendai
Reprogramming Kit (Thermo Fisher Scientiﬁc), according the
manufacturer's instructions. 20 days post-infection, optimal iPSC-like
colonies were marked, picked and transferred in Essential 8 medium
(E8 medium; Thermo Fisher Scientiﬁc) on Geltrex-coated wells. Both
MMD HEM#30 iPSC line and commercial hiPSC line (GIBCO, Thermo
Fisher Scientiﬁc) were maintained in E8 medium, performing daily me-
dium change and regular splitting every 3–4 days with an EDTA-based
dissociation solution.
In vitro differentiation
hiPSCs were collected and dissociated in cell clumps, plated in low
attachment wells in 4 ml of Essential 8 medium supplemented with
2 mg/ml of PVA (polyvinyl alcohol, Santa Cruz Biotechnology) anddies culture (5×). After 14 days, differentiated cultures exhibited the presence of cells
MA-1) (20×) germ-layers markers. B: FGF5 (ectoderm), Nestin (neuro-ectoderm), T-
comparable between 14 days differentiated EBs cultures obtained from MMD HEM#30
Table 1
List of primer sequences, amplicon sizes and number of PCR cycles.
Gene Primer sequence Amplicon size Cycles (PCR)
β actin F:GACAGGATGCAGAAGGAGATTACTG R: CTCAGGAGGAGCAATGATCTTGAT 72 bp 25
OCT4 F: GGAAGGAATTGGGAACACAAAGG R: AACTTCACCTTCCCTCCAACCA 71 bp 30
SOX2 F: GCTACAGCATGATGCAGGACCA R: TCTGCGAGCTGGTCATGGAGTT 135 bp 30
c-Myc F: CCTGGTGCTCCATGAGGAGAC R: CAGACTCTGACCTTTTGCCAGG 128 bp 30
KLF4 F: CATCTCAAGGCACACCTGCGAA R: TCGGTCGCATTTTTGGCACTGG 156 bp 30
Nanog F: CCTGTGATTTGTGGGCCTG R: GACAGTCTCCGTGTGAGGCAT 78 bp 30
SeV F:GGATCACTAGGTGATATCGAGC R: ACCAGACAAGAGTTTAAGAGATATGTATC 181 bp 35
Nestin F: GGAGAAGGACCAAGAACTG R: ACCTCCTCTGTGGCATTC 153 bp qRT-PCR
T-Brachyury F: CCTTCAGCAAAGTCAAGCTCACC R: TGAACTGGGTCTCAGGGAAGCA 153 bp qRT-PCR
FGF5 F: GGAATACGAGGAGTTTTCAGCAAC R: CTCCCTGAACTTGCAGTCATCTG 99 bp qRT-PCR
AFP F: GCAGAGGAGATGTGCTGGATTG R: CGTGGTCAGTTTGCAGCATTCTG 113 bp qRT-PCR
β3-Tubulin F: TCAGCGTCTACTACAACGAGGC R: GCCTGAAGAGATGTCCAAAGGC 120 bp qRT-PCR
GAPDH F: CCACTCCTCCACCTTTGAC R: ACCCTGTTGCTGTAGCCA 102 bp qRT-PCR
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gregates were shifted to a 1:1 mix of Essential 6 medium (E6 medium;
Thermo Fisher Scientiﬁc) and E8 medium supplemented with 2 mg/ml
of PVA. From the following day until the end of the experiment, cells
were maintained in E6 medium. At day 7, Embryoid Bodies (EBs)
were collected and plated on Geltrex-coated wells, and let to differenti-
ate for further 7 days. Medium was changed every other day.
RNA isolation, polymerase chain reaction (PCR) and quantitative-PCR
(qPCR)
RNAwas isolatedwith the TRIzol Reagent (Thermo Fisher Scientiﬁc)
following the manufacture's protocol, then retro-transcribed with
iScript cDNA Synthesis Kit (BioRad). cDNA was used to verify the ex-
pression of speciﬁc target genes by RT-PCR (Reverse Transcription-
PCR, primers reported in Table 1) or qRT-PCR (quantitative RT-PCR),
using the SsoAdvanced Universal SYBR Green Supermix Kit. qRT-PCR
data were analyzed according to the comparative ΔΔCt method and
normalized by using GAPDH housekeeping gene.
Immunoﬂuorescence analysis
Cells were ﬁxed in PFA 4% for 15 min at room temperature, perme-
abilizedwith Triton 0.3% for 10min at room temperature, and incubated
in blocking solution (FBS 5%, Triton 0.3% in PBS) for 1 h. Hybridization
with the primary antibodies reported in the Table 2 was performed
overnight at 4 °C in antibody solution (FBS 2% and Triton 0.2% in PBS).
The signal was revealed by the appropriate secondary antibodies
(Table 2), while nuclei were counterstained with Hoechst 33258 1 μg/
ml (Thermo Fisher Scientiﬁc). Images were acquired with the micro-
scope Leica DM IL Led Fluo and the camera Leica DFC450 C (Leica
Microsystem).Table 2
List of the antibodies used in for immunocytochemistry (IC) and Western Blot (WB) assays, w
Antibody Company
TRA 1–60 Santa Cruz Biotech
Nanog Santa Cruz Biotech
SOX2 Millipore
OCT4 Santa Cruz Biotech
α-SMA Sigma
TROMA-1 Iowa DHB
β3-Tubulin Promega
Anti-rabbit HRP BioRad
Anti-mouse HRP BioRad
Anti-mouse IgM FITC Santa Cruz Biotech
Alexa Fluor IgG anti-rabbit 568 Life Technologies
Alexa Fluor IgG anti-rabbit 488 Life Technologies
Alexa Fluor IgG anti-mouse 568 Life Technologies
Alexa Fluor IgG anti-mouse 488 Life TechnologiesWestern blot assay
Cells were lysed in RIPA buffer and 20 μg of total lysate were frac-
tionated on 8% SDS-polyacrylamide gel, blotted onto PVDF membranes
with the TransBlot Turbo apparatus (BioRad) and hybridized overnight
at 4 °C with the primary antibodies (Table 2). The signal was detected
with appropriate HRP-conjugated secondary antibodies (BioRad) and
ECL Clarity system (BioRad), using the chamber UVITECH Cambridge
(Uvitech).Karyotyping
Cell cultureswere treatedwith 10ng/ml colcemid (Gibco KaryoMAX
Colcemid solution in PBS, Thermo Fisher Scientiﬁc) for 16 h (overnight)
at 37 °C. Metaphases were collected according to standard protocols.
Brieﬂy, cells were incubated with hypotonic solution (0.075 M KCl for
15 min at room temperature) and ﬁxed in acetic acid/methanol
(1:3 v/v). Air-dried metaphase spreads slides were then analyzed by
QFQ banding. Microscope observation was performed using a Nikon
Eclipse 90i (Nikon Instruments) equipped with the acquisition and
analysis Genikon software (Nikon Instruments).Acknowledgements
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Dilution Species
1:1000 (WB) 1:200 (IC) Mouse IgM
1:1000 (WB) 1:100 (IC) Mouse
1:2000 (WB) 1:300 (IC) Rabbit
1:1000 (WB) 1:100 (IC) Rabbit
1:1000 (IC) Mouse
1:100 (IC) Mouse
1:1000 (IC) Mouse
1:3000 Goat
1:3000 Goat
1:200 Goat
1:300 Goat
1:300 Goat
1:300 Goat
1:300 Goat
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